# MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial

Study · id `cardio:ct-nct03135275` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03135275](<https://clinicaltrials.gov/study/NCT03135275>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03135275

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 840 participants.

## Technical summary

Registry record NCT03135275. Randomized; no masking; primary purpose treatment. Start 2016-10 (actual); primary completion 2023-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 840 participants (planned count; ClinicalTrials.gov record NCT03135275, source copy `cardio:ctgov-nct03135275-2024-01-11`, retrieved 2026-10-26)
- Started: 2016-10 (actual) (ClinicalTrials.gov record NCT03135275, source copy `cardio:ctgov-nct03135275-2024-01-11`, retrieved 2026-10-26)
- Primary completion: 2023-05 (actual) (ClinicalTrials.gov record NCT03135275, source copy `cardio:ctgov-nct03135275-2024-01-11`, retrieved 2026-10-26)
- Completion: 2023-05 (actual) (ClinicalTrials.gov record NCT03135275, source copy `cardio:ctgov-nct03135275-2024-01-11`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT03135275, source copy `cardio:ctgov-nct03135275-2024-01-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03135275-2024-01-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial
- Acronym: MULTISTARS AMI
- Condition: ST-elevation Myocardial Infarction
- Condition: Multivessel Coronary Disease
- Intervention (Procedure): Staged complete PCI
- Intervention (Procedure): Immediate complete PCI
- Intervention (Device): Synergy™ stent
- Lead sponsor: University of Zurich
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: University of Zurich (`cardio:org-university-of-zurich`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction (`cardio:pubmed-37634190`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trial (`cardio:pubmed-41801439`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b49080745a7f8ab5a8706747426740a4c93e96386ae2ad3c6b7f1a072532968e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
